News
VIENNA, Austria I June 30, 2025 I invIOs GmbH (“invIOs”), a privately held biotechnology company focused on developing innovative cancer immunotherapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback